# Zhejiang Excel Pharmaceutical Company, Ltd. – FDA Inspection, Apr 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-excel-pharmaceutical-company-ltd/a870df77-720e-41a2-b2f7-0c5cc129b484
Source feed: FDA_Inspections

> FDA inspection 1233323 of Zhejiang Excel Pharmaceutical Company, Ltd., April 12, 2024. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233323
- Company Name: Zhejiang Excel Pharmaceutical Company, Ltd.
- Inspection Date: 2024-04-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 963958 - 2016-04-01
- FDA Inspection 819131 - 2013-01-31
- FDA Inspection 565822 - 2009-01-28

## Related Officers

- [Investigator](https://www.keypedia.com/people/damaris-y-hernandez/ca16093e-047b-4bf1-bcc1-c439cff21e8a)
- [FDA Associated Person](https://www.keypedia.com/people/suzanne-n-vallez/7c16e0f4-c0b1-4f50-adfa-b1dc534694cd)

Company: https://www.keypedia.com/companies/zhejiang-excel-pharmaceutical-company-ltd/4895da03-f853-4a18-b30d-9b4a3dbc3189

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c